[Treatment with selective and reversible monoamine oxidase inhibitors in depressed patients: is there a biological effect proportional to the dose?].
Radat
F
F
Hôpital Saint-Antoine, serv. du Pr Ferreri, Paris.
Berlin
I
I
Varoquaux
O
O
Ferreri
M
M
Puech
A
A
D000928:Antidepressive Agents / Q000008:administration & dosage* / Q000378:metabolism; D001549:Benzamides / Q000008:administration & dosage* / Q000378:metabolism; D003866:Depressive Disorder / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D008297:Male; D020912:Moclobemide; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage* / Q000378:metabolism; D011569:Psychiatric Status Rating Scales
D000928:Antidepressive Agents; D001549:Benzamides; D008996:Monoamine Oxidase Inhibitors; D020912:Moclobemide
Traitement par inhibiteurs sélectifs et réversibles de la monoamine oxydase chez des patients déprimés : existe-t-il un effet biologique proportionnel à la dose?